Black Triangle Scheme And Formal Inspections On the Cards In Australia
Executive Summary
New pharmacovigilance-enhancing proposals from Australia’s Therapeutic Goods Administration signal the agency’s intention to become more proactive when it comes to monitoring drug sponsors.